#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4742444	B	Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay	Homo sapiens	32	ALA4742387	protein complex format	Patent Bioactivity Data
2.	ALA4742445	B	Inhibition of GST-tagged recombinant human haspin kinase domain incubated for 60 mins by ADP-Glo luminescent kinase assay	Homo sapiens	32	ALA4742387	single protein format	Patent Bioactivity Data
3.	ALA4742446	B	Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK19/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay	Homo sapiens	20	ALA4742387	protein complex format	Patent Bioactivity Data
4.	ALA4742449	B	Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis	Homo sapiens	14	ALA4742387	cell-based format	Patent Bioactivity Data
5.	ALA4742451	F	Antiproliferative activity against human MV4-11 cells assessed as reduction in cell proliferation by CellTiter-Glo luminescent cell viability assay	Homo sapiens	24	ALA4742387	cell-based format	Patent Bioactivity Data
6.	ALA4742452	F	Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell proliferation by CellTiter-Glo luminescent cell viability assay	Homo sapiens	24	ALA4742387	cell-based format	Patent Bioactivity Data
7.	ALA4742453	F	Antiproliferative activity against human SW-620 cells assessed as reduction in cell proliferation by CellTiter-Glo luminescent cell viability assay	Homo sapiens	27	ALA4742387	cell-based format	Patent Bioactivity Data
8.	ALA4742454	F	Antiproliferative activity against human MOLM-13 cells assessed as reduction in cell proliferation by CellTiter-Glo luminescent cell viability assay	Homo sapiens	22	ALA4742387	cell-based format	Patent Bioactivity Data